Increased Rate of Visual Field Loss Associated with Larger Initial Visual Field Threshold Values on Follow-Up of Open-Angle Glaucoma

Journal of Glaucoma

Volumn 13, Issue 2, 2004, Pages 120-129

  Schwartz, Bernard ^a,b,c   Takamoto, Takenori ^a   Martin, Jeff ^a  

^a Glaucoma Research Foundation   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Glaucoma; Progression; Visual fields

Indexed keywords

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; EYE FUNDUS; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; OPTIC DISK; PRIORITY JOURNAL; REVIEW; VISUAL FIELD DEFECT;

DIFFERENTIAL THRESHOLD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIMETRY; RETROSPECTIVE STUDIES; SENSORY THRESHOLDS; VISION DISORDERS; VISUAL FIELDS;

EID: 1642385438     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200404000-00007     Document Type: Review

References (42)

1. O'Brien C, Schwartz B. The visual field in chronic open angle glaucoma: The rate of change in different regions of the field. Eye. 1990;4:557-562.
2. O'Brien C, Schwartz B, Takamoto T, et al. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol. 1991;11:491-500.
3. Wu D, Schwartz B, Nagin P. Trend analyses of automated visual fields. Proc International Perimetric Society. Dr. W. Junk Publishers, Dordrecht. The Netherlands. Doc Ophthalmol Proc. 1987;49:175-189.
4. Fitzke FW, Hitchings RA, Poinoosawmy, et al. Analysis of visual field progression in glaucoma. Br J Ophthalmol. 1996;80:40-48.
5. Wild JM, Hutchings N, Hussey MK, et al. Pointwise univariate linear regression of perimetric sensitivity against follow-up time in glaucoma. Ophthalmology. 1997;104:808-815.
6. Crick RP, Vogel R, Newson RB, et al. The visual field in chronic simple glaucoma and ocular hypertension; Its character, progress relationship to the level of intraocular pressure and response to treatment. Eye. 1989;3:536-546.
7. Shirakashi M, Iwata K, Sawaguchi S, et al. Intraocular pressure-dependent progression of visual field loss in advanced primary open-angle glaucoma: A 15-year follow-up. Ophthalmologica. 1993;207:1-5.
8. The AGIS Investigators. The advanced glaucoma intervention study (AGIS). The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429-440.
9. Scheie HG. Width and pigmentation of the angle of the anterior chamber. A system of grading by gonioscopy. Arch Ophthalmol. 1956;58:510-512.
10. Gramer E, Gerlach R, Krieglstein GK, et al. Zür Topogrophie früher glaukomatoser Gesichtsfeldaustfälle bei der Computerperimetrie. Klin Monatsbl Augenbeilkd. 1982;180:515-523.
11. Wirtschafter JD, Becker WL, Howe JB, et al. Glaucoma visual field analysis by computed profile of nerve fiber layer function in optic disc sectors. Ophthalmology. 1982;89:255-267.
12. Schwartz B, Nagin P. Probability maps for evaluating automated visual fields. In: Heijl A, Greve EL, eds. Proceedings of the VI International Visual Field Symposium. Dr. W. Junk; Dordrecht, The Netherlands; 1985:39-48.
13. Bengtsson B, Krakau CET. Correction of optic disc measurements on fundus photographs. Graefes Arch Clin Exp Ophthalmol. 1992;320:24-28.
14. Siegel S, Castellon NJ Jr. Nonparametric statistics for the behavioral sciences. 2nd ed. New York: McGraw-Hill Book Co.; 1988.
15. Kleinbaum DG, Kupper LL. Applied regression analyses and other multivariate methods. 3rd ed. North Scituate, MA: Duxbury Press; 1998.
16. Garway-Heath DF, Caprioli J, Fitzke FW, et al. Scaling the hill of vision: The physiological relationship between light sensitivity and ganglion cell numbers. Invest Ophthalmol Vis Sci. 2000;41:1774-1782.
17. Krakau CET. Hazards in evaluation of visual field decay. Doc Ophthalmol. 1986;63:239-246.
18. Spry PGD, Bates AB, Johnson CA, et al. Simulation of longitudinal threshold visual field data. Invest Ophthalmol Vis Sci. 2000;41:2192-2200.
19. Jonas JB, Budde WM. Diagnosis and pathogenesis of glaucomatous optic neuropathy. Morphological aspects. Prog Retin Eye Res. 2000;19:1-40.
20. Smith SC, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1419-1428.
21. Katz J, Gilbert D, Quigley HA, et al. Estimating progression of visual field loss in glaucoma. Ophthalmology. 1997;104:1017-1025.
22. Lichter P, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943-1953.
23. Kwon YH, Kim C-S, Zimmerman MB, et al. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol. 2001;132:47-56.
24. Heijl A, Leske MC, Bengtsson, et al. Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand. 2003;81:286-293.
25. Rasker MTE, van den Enden A, Bakker D, et al. Rate of visual field loss in progressive glaucoma. Arch Ophthalmol. 2000;118:481-488.
26. The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthamol. 2002;134:499-512.
27. Tarek M, Spaeth GL, Bitterman A, et al. Rate and amount of visual loss in 102 patrients with open-angle glaucoma followed up for at least 15 years. Ophthalmology. 2003;110:900-907.
28. Olivius E, Thorburn W. Prognosis of glaucoma simplex and glaucoma capsulare. A comparative study. Acta Ophthalmol (Copenh). 1978;56:921-934.
29. Wilson R, Walker AM, Dueker DK, et al. Risk factors for rate of progression of glaucomatous visual field loss. A computer-based analysis. Arch Opthalmol. 1982;100:737-741.
30. Granström P-A. Progression of visual field defects in glaucoma. Relation to compliance with pilocarpine therapy. Arch Ophthalmol. 1995;103:529-531.
31. Mikelberg FS, Schulzer M, Drance SM, et al. The rate of progression of scotomas in glaucoma. Am J Ophthalmol. 1986;101:1-6.
32. Berggren L, Widengard I. Visual impairment of open-angle glaucomas at first presentation and after a five to ten year follow-up. Upsala J Med Sci. 1992;97:251-260.
33. Gramer E. Risk factors in glaucoma clinical studies. In: Glaucoma Update V. GK Krieglstein, ed. Kaden Verlag: Heidelberg; 1995:14-31.
34. Odberg T. Visual field prognosis in advanced glaucoma. Acta Ophthalmol. 1987;65(Suppl 182):27-29.
35. Schultz JS, Werner EB, Krupin T, et al. Intraocular pressure and visual field defects after argon laser trabeculoplasty in chronic open-angle glaucoma. Ophthalmology. 1987;94:553-557.
36. Dallas NL, Sponsel WE, Hobley AJ. A comparative evaluation of timolol maleate and pilocarpine in the treatment of chronic open angle glaucoma. Eye. 1988;2:243-249.
37. Mao LK, Stewart WC, Shields MB. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol. 1991;111:51-55.
38. Stewart WC, Kolken AE, Sharpe ED, et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol. 2000;130:274-279.
39. Holmin C, Storr-Paulsen A. The visual field after trabeculectomy. A follow-up study using computerized perimetry. Acta Ophthalmol (Copenh). 1984;62:230-234.
40. Jay JL, Allan D. The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease. Eye. 1989;3:528-535.
41. Suzuki Y, Shirato S, Adachi M, et al. Risk factors for the progression of treated primary open-angle glaucoma: A multivariate life-table analysis. Graefes Arch Clin Exp Ophthalmol. 1999;237:463-467.
42. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.